Sean Salmon - 02 Aug 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Pres Diabetes/Cardiovasc
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
02 Aug 2021
Net transactions value
-$298,336
Form type
4
Filing time
04 Aug 2021, 18:24:25 UTC
Next filing
26 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Tax liability $298,336 -2,272 -7.5% $131.31 27,843 02 Aug 2021 Direct F1, F2
transaction MDT Ordinary Shares Award $0 +5,486 +20% $0.000000 33,329 02 Aug 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Award $0 +46,867 $0.000000 46,867 02 Aug 2021 Ordinary Shares 46,867 $131.26 Direct F4
transaction MDT Stock Option (Right to Buy) Award $0 +1,085 $0.000000 1,085 02 Aug 2021 Ordinary Shares 1,085 $131.26 Direct F4
transaction MDT Performance Share Units Award $0 +13,714 $0.000000 13,714 02 Aug 2021 Performance Share Units 13,714 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment.
F2 This balance increased by 163 shares due to exempt transactions such as dividend reinvestment.
F3 The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F4 These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
F5 Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F6 The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 13,714 shares will be issued. The actual number of shares to be issued could range from a low of 2,743 at minimum performance to a high of 27,428 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F7 Vests on August 2, 2024.